Direct oral anticoagulants are associated with potentially bleeding lesions in suspected mid-gastrointestinal bleeding

References

• Chaudhary R, Sharma T, Garg J, et al. Direct oral anticoagulants: a review on the current role and scope of reversal agents. J Thromb Thrombolysis. 2020;49(2):271–286.
   PubMed Web of Science ®Google Scholar
• Desai J, Kolb JM, Weitz JI, et al. Gastrointestinal bleeding with the new oral anticoagulants—defining the issues and the management strategies. Thromb Haemost. 2013;110(2):205–212.
   PubMed Web of Science ®Google Scholar
• Miller CS, Dorreen A, Martel M, et al. Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(11):1674–1683.e3.
   PubMed Web of Science ®Google Scholar
• Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management. World J Gastroenterol. 2017;23(11):1954–1963.
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123(21):2363–2372.
   PubMed Web of Science ®Google Scholar
• Pennazio M, Spada C, Eliakim R, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2015;47(4):352–376.
   PubMed Web of Science ®Google Scholar
• Rosa B, Cotter J. Current clinical indications for small bowel capsule endoscopy. Acta Med Port. 2015;28(5):632–639.
   PubMed Web of Science ®Google Scholar
• Spada C, McNamara D, Despott EJ, et al. Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2019;7(5):614–641.
   PubMed Web of Science ®Google Scholar
• Saurin JC, Delvaux M, Gaudin JL, et al. Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy. 2003;35(7):576–584.
   PubMed Web of Science ®Google Scholar
• Boal Carvalho P, Rosa B, Moreira MJ, et al. New evidence on the impact of antithrombotics in patients submitted to small bowel capsule endoscopy for the evaluation of obscure gastrointestinal bleeding. Gastroenterol Res Pract. 2014;2014:709217.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340.
   PubMed Web of Science ®Google Scholar
• Verbeke F, Lindley E, Van Bortel L, et al. A European Renal Best Practice (ERBP) position statement on the kidney disease: improving global outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. Nephrol Dial Transplant. 2014;29(3):490–496.
   PubMed Web of Science ®Google Scholar
• Rondonotti E, Spada C, Adler S, et al. Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) technical review. Endoscopy. 2018;50(4):423–446.
   PubMed Web of Science ®Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–962.
   PubMed Web of Science ®Google Scholar
• Feagins LA, Weideman RA. GI bleeding risk of DOACs versus warfarin: is newer better? Dig Dis Sci. 2018;63(7):1675–1677.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151.
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891.
   PubMed Web of Science ®Google Scholar
• Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–2104.
   PubMed Web of Science ®Google Scholar
• Holster IL, Valkhoff VE, Kuipers EJ, et al. New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology. 2013;145(1):105–112.e15.
   PubMed Web of Science ®Google Scholar
• Peacock WF, Rafique Z, Singer AJ. Direct-acting oral anticoagulants: practical considerations for emergency medicine physicians. Emerg Med Int. 2016;2016:1781684.
   PubMed Web of Science ®Google Scholar
• Di Minno A, Spadarella G, Spadarella E, et al. Gastrointestinal bleeding in patients receiving oral anticoagulation: current treatment and pharmacological perspectives. Thromb Res. 2015;136(6):1074–1081.
   PubMed Web of Science ®Google Scholar
• Goodman SG, Wojdyla DM, Piccini JP, et al. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol. 2014;63(9):891–900.
   PubMed Web of Science ®Google Scholar
• Hylek EM, Held C, Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation): predictors, characteristics, and clinical outcomes. J Am Coll Cardiol. 2014;63(20):2141–2147.
   PubMed Web of Science ®Google Scholar
• Hann A, Graf L, Seufferlein T, et al. Gastrointestinal bleeding diagnosed by capsule endoscopy – a change towards more patients with bleeding-related drugs. J Adv Med Med Res. 2020;32(19):1–10.
   Google Scholar
• Desai NR, Krumme AA, Schneeweiss S, et al. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation – quality and cost implications. Am J Med. 2014;127(11):1075–1082.e1.
   PubMed Web of Science ®Google Scholar
• Olano C, Pazos X, Avendaño K, et al. Diagnostic yield and predictive factors of findings in small-bowel capsule endoscopy in the setting of iron-deficiency anemia. Endosc Int Open. 2018;6(6):E688–E693.
   PubMed Web of Science ®Google Scholar
• Nagata N, Niikura R, Yamada A, et al. Acute middle gastrointestinal bleeding risk associated with NSAIDs, antithrombotic drugs, and PPIs: a multicenter case-control study. PLOS One. 2016;11(3):e0151332.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. J Gastroenterol. 2020;55(5):481–495.
   PubMed Web of Science ®Google Scholar
• Igawa A, Oka S, Tanaka S, et al. Major predictors and management of small-bowel angioectasia. BMC Gastroenterol. 2015;15:108.
   PubMed Web of Science ®Google Scholar
• Cúrdia Gonçalves T, Magalhães J, Boal Carvalho P, et al. Is it possible to predict the presence of intestinal angioectasias? Diagn Ther Endosc. 2014;2014:1–6.
   Google Scholar
• Muftah M, Mulki R, Dhere T, et al. Diagnostic and therapeutic considerations for obscure gastrointestinal bleeding in patients with chronic kidney disease. Ann Gastroenterol. 2019;32(2):113–123.
   PubMed Web of Science ®Google Scholar
• Yamaoka M, Imaeda H, Hosoe N, et al. Small-bowel lesions in patients taking direct oral anticoagulants detected using capsule endoscopy. Gastroenterol Res Pract. 2020;2020:7125642.
   PubMed Web of Science ®Google Scholar
• Chan YH, See LC, Tu HT, et al. Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation. J Am Heart Assoc. 2018;7(8):e008150.
   PubMed Web of Science ®Google Scholar
• Blech S, Ebner T, Ludwig-Schwellinger E, et al. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. Drug Metab Dispos. 2008;36(2):386–399.
   PubMed Web of Science ®Google Scholar
• Abraham NS, Noseworthy PA, Yao X, et al. Gastrointestinal safety of direct oral anticoagulants: a large population-based study. Gastroenterology. 2017;152(5):1014–1022.e1.
   PubMed Web of Science ®Google Scholar